These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8391287)

  • 1. Gene therapy: a bold direction for HIV-1 treatment.
    Sarver N; Rossi J
    AIDS Res Hum Retroviruses; 1993 May; 9(5):483-7. PubMed ID: 8391287
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cells, ribozymes and HIV.
    Burnett JC; Rossi JJ
    Gene Ther; 2009 Oct; 16(10):1178-9. PubMed ID: 19641534
    [No Abstract]   [Full Text] [Related]  

  • 3. Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
    Zaia JA; Chatterjee S; Wong KK; Elkins D; Taylor NR; Rossi JJ
    Ann N Y Acad Sci; 1992 Oct; 660():95-106. PubMed ID: 1340161
    [No Abstract]   [Full Text] [Related]  

  • 4. Can gene delivery close the door to HIV-1 entry after escape?
    Swan CH; Torbett BE
    J Med Primatol; 2006 Aug; 35(4-5):236-47. PubMed ID: 16872287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection.
    Morris KV; Rossi JJ
    Hum Gene Ther; 2006 May; 17(5):479-86. PubMed ID: 16716105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards gene therapy for HIV infection.
    Yu M; Poeschla E; Wong-Staal F
    Gene Ther; 1994 Jan; 1(1):13-26. PubMed ID: 7584055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology evaluation: StealthVector (HIV) Enzo.
    Günzburg W; Mhashilkar AM; Hindi M
    Curr Opin Mol Ther; 1999 Oct; 1(5):651-7. PubMed ID: 11249672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of antisense DNA by vectors for prolonged effects in vitro and in vivo.
    Mohuczy D; Tang X; Phillips MI
    Methods Enzymol; 2000; 314():32-51. PubMed ID: 10565003
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of ribozyme gene therapy for HIV infection.
    Wong-Staal F
    Antibiot Chemother (1971); 1996; 48():226-32. PubMed ID: 8726529
    [No Abstract]   [Full Text] [Related]  

  • 10. Current developments in anti-HIV/AIDS gene therapy.
    Tsygankov AY
    Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins.
    Cooper D; Penny R; Symonds G; Carr A; Gerlach W; Sun LQ; Ely J
    Hum Gene Ther; 1999 May; 10(8):1401-21. PubMed ID: 10365669
    [No Abstract]   [Full Text] [Related]  

  • 13. Human immunodeficiency virus type I as a target for gene therapy.
    Gottfredsson M; Bohjanen PR
    Front Biosci; 1997 Dec; 2():d619-34. PubMed ID: 9388165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.
    Amado RG; Mitsuyasu RT; Rosenblatt JD; Ngok FK; Bakker A; Cole S; Chorn N; Lin LS; Bristol G; Boyd MP; MacPherson JL; Fanning GC; Todd AV; Ely JA; Zack JA; Symonds GP
    Hum Gene Ther; 2004 Mar; 15(3):251-62. PubMed ID: 15018734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral delivery and anti-HIV testing of hammerhead ribozymes.
    Cagnon L; Rossi J
    Methods Mol Biol; 1997; 74():451-7. PubMed ID: 9204460
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1.
    Morris KV; Looney DJ
    Hum Gene Ther; 2005 Dec; 16(12):1463-72. PubMed ID: 16390277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy.
    Hörster A; Teichmann B; Hormes R; Grimm D; Kleinschmidt J; Sczakiel G
    Gene Ther; 1999 Jul; 6(7):1231-8. PubMed ID: 10455431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency.
    Cruz PE; Mueller C; Flotte TR
    Pharmacogenomics; 2007 Sep; 8(9):1191-8. PubMed ID: 17924834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozymes: killing the messenger.
    Barinaga M
    Science; 1993 Dec; 262(5139):1512-4. PubMed ID: 8248799
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene therapy and gene transfer approaches to prevent or treat chronic virus infections.
    Berkout B; Ertl HC; Weinberg MS
    Adv Exp Med Biol; 2015; 848():v-vii. PubMed ID: 26034787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.